HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

CAH

Cardinal Health, Inc. (S&P 500)

Healthcare — Medical Distribution

Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company offers customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile and non-sterile procedure kits. Additionally, it manufactures, prepares, and delivers radiopharmaceuticals; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Buy 1.5 / 5 15 analysts
$230.09
+$7.59 (+3.41%)
Target: $270.33 (17.5%)

Price History

52-Week Range
Sign in to add CAH to a watchlist or set price alerts.

Fundamentals

Market Cap$53.28B
P/E Ratio (TTM)31.82
Forward P/E16.37
EPS (TTM)$7.23
Dividend Yield0.93%
Profit Margin0.67%
Revenue Growth5.80%
ROE-
Debt/Equity-
Recommendation Buy 1.5
Analyst Target$270.33
Analysts15
Next Earnings Nov 5, 2026 BMO
Indexes S&P 500

Technical Indicators

RSI (14)42.8
Beta0.52
SMA 20$230.37
SMA 40$233.02
52-Week High$258.30
52-Week Low$150.78
50-Day Avg$232.43
200-Day Avg$217.73
Avg Volume$1.99M
Volume$1.71M

Performance Analysis

BULLISH

CAH shows predominantly bullish signals based on its fundamentals and technicals.

+ Showing strength at 74% of its 52-week range.
~ RSI at 42.8 is in neutral territory.
~ Price dropped below the 50-day average but remains above the 200-day — possible short-term weakness.
~ Modest revenue growth of 5.8% year-over-year.
+ Wall Street consensus is "Buy" from 15 analysts.
+ Average analyst target of $270.33 implies 17.5% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Oct 01, 2026 21:00 UTC

Back to Screener Export Report